Ether

Ether

SCHEMBL2582269

C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.CCOCC.OCCO

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
TSHR P16473 5/20 0.36
MAPK1 P28482 1/20 0.33
THRB P10828 2/20 0.32
PPARD Q03181 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HTT P42858 1/20 0.31
MAPT P10636 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL989838 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD
Ether SCHEMBL9639185 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD
Ether SCHEMBL5483916 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD
Ether SCHEMBL466516 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD
Ether SCHEMBL1173072 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD
Ether SCHEMBL5575028 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD
Ether SCHEMBL23356828 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD
Ether SCHEMBL15741360 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD
Ether SCHEMBL1419841 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD
Ether SCHEMBL987826 1.00 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1THRBPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110201603-B Cationic surfactant and preparation method thereof 湖南华腾制药有限公司 2021-08-13 CN disclosed
CN-111036136-A Novel cationic surfactant and preparation method thereof 湖南华腾制药有限公司 2020-04-21 CN disclosed
EP-2673000-B1 POLYMER-CARBOHYDRATE-LIPID CONJUGATES WU NIAN (US) 2018-05-16 EP disclosed
US-9175027-B2 Polymer-carbohydrate-lipid conjugates LIPOSEUTICALS, INC. 2015-11-03 US disclosed
WO-2012109052-A1 POLYMER-CARBOHYDRATE-LIPID CONJUGATES WU NIAN (US) 2012-08-16 WO disclosed
US-20120202979-A1 POLYMER-CARBOHYDRATE-LIPID CONJUGATES LIPOSEUTICALS, INC. 2012-08-09 US disclosed
WO-2011139343-A2 AMINO ACID LINKED PEG-LIPID CONJUGATES WU NIAN (US) 2011-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202979-A1 POLYMER-CARBOHYDRATE-LIPID CONJUGATES LIPC, FUT6, UGCG ALDH1A1 873/4885TSHR 3962/4885MAPK1 2125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.